Medical organizations are at odds over new guidance that recommends easing hemoglobin A1C (HbA1c) targets for patients with type 2 diabetes. The updated guidance statement from the American College of Physicians (ACP), which focuses on glycemic control with medications, says clinicians should personalize goals and aim to achieve an HbA1c level of between 7% and 8% for most patients with type 2 diabetes.
Abbasi J. For Patients With Type 2 Diabetes, What’s the Best Target Hemoglobin A1C? JAMA. 2018;319(23):2367–2369. doi:10.1001/jama.2018.5420
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: